CBGA (Cannabigerolic Acid)
The Mother Cannabinoid
CBGA (Cannabigerolic Acid) is the chemical precursor to THC, CBD, and CBC. As the plant matures, enzymes convert CBGA into these other compounds, leaving only trace amounts of CBG.
Chemical role
Precursor to THC, CBD, and CBC
Conversion process
Enzymatic transformation during plant maturation
Final concentration
Trace amounts of CBG remain
Key Biological Mechanisms
Adrenoceptor Interaction
Unlike CBD, CBG is a potent α2-adrenoceptor agonist and a moderate 5-HT1A antagonist, giving it unique potential for blood pressure regulation and cognitive focus.
Direct Receptor Affinity
CBG has a higher binding affinity for both CB1 and CB2 receptors compared to CBD, making it more "active" in the endocannabinoid system.
Latest 2025–2026 Research Highlights
Breakthrough studies in CBG research
Dermatological Breakthrough
A landmark study published in MDPI demonstrated that topical CBG acts as a dual-pathway modulator in skin conditions like rosacea. It significantly reduced erythema (redness) by suppressing the JAK/STAT and YAP/TAZ signaling pathways.
Cancer Research
Research in PubMed found that CBG exhibits a high affinity for HER2-tyrosine kinase, suggesting it may inhibit the growth of certain ovarian cancer cells in adjunct therapy settings.